Psoriasis and Psoriatic Disorders Clinical Trials

A listing of Psoriasis and Psoriatic Disorders medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

Dermatology Specialists, Inc.
Oceanside California 92056

A national, multi-center, randomized, double-blind, 4 arm, 8 week study in subjects with psoriasis vulgaris on the non-scalp regions of the body (trunk and/or limbs)

Dermatology Specialists, Inc.
Oceanside California 92056

A Phase 3, Multi-site, randomized, mixed-blind, parallel-group treatment withdrawl and re-treatment study of the efficacy and safety of 2 oral doses of CP-690,550 in Subjects with Moderate to Severe Chronic Plaque Psoriasis

Dermatology Specialists, Inc.
Oceanside California 92056

You may be interested in learning about a clinical research study of an investigational study medication for symptoms associated with plaque psoriasis

Colorado

Colorado Medical Research Center
Denver Colorado 80210

Are you suffering from moderate to severe plaque psoriasis?

Colorado Medical Research Center, Inc.
Denver Colorado 80210

Are you suffering from moderate to severe plaque psoriasis?

Horizons Clinical Research Center, LLC
Denver Colorado 80220

Research Studies for the Treatment of PSORIASIS

Florida

University of South Florida - Morsani Center for Advanced Healthcare
Tampa Florida 33612

A multicenter open label uncontrolled study of the long term safety and efficacy of calcitriol 3mcg/g ointment applied twice daily for 26 weeks in pediatric subjects (2 to 17 years of age) with mild to moderate plaque psoriasis

Georgia

Columbus Regional Research Institute
Columbus Georgia 31904

Considering potential research options for managing psoriasis?

Indiana

Maryland

PAREXEL
Baltimore Maryland 21225

CHRONIC PLAQUE PSORIASIS

PAREXEL
Baltimore Maryland 21225

HIDRADENITIS SUPPURATIVA

PAREXEL
Baltimore Maryland 21225

PALMOPLANTAR PUSTULOSIS

Massachusetts

ActivMed Practices & Research, Inc
Beverly Massachusetts 01915

Are you Suffering from Chronic Plaque Psoriasis?

Missouri

MediSearch Clinical Trials
St. Joseph Missouri 64506

A 30-day study evaluating a topical corticosteroid spray.

New Jersey

Psoriasis Treatment Center of Central New Jersey
East Windsor New Jersey 08520

A phase 2A, randomized, double-blind, placebo-controoled, study to evaluate safety and efficacy of PF-06700841 in subjects with moderate to severe plaque psoriasis.

Psoriasis Treatment Center of Central New Jersey
East Windsor New Jersey 08520

A phase 3, multi-center, randomized, placebo controlled, double-blind, study of the efficacy and safety of apremilast (CC-1004) in subjects with moderate to severe plaque psoriasis of the scalp.

Psoriasis Treatment Center of Central New Jersey
East Windsor New Jersey 08520

A randomized, double-blind, placebo-controoled, parallel-group, multicenter study to explore changes in subcutaneous adipose tissue and modulation of skin inflammation after 12 weeks of treatment with secukinumab in adult patients with moderate to severe plaque psoriasis.

New York

Sadick Research Group
New York New York 10075

A Clinical Study to Assess the Safety and Efficacy of KD025 Administered Orally to Patients with Moderate to Severe Chronic Plaque Psoriasis

Sadick Research Group
New York New York 10075

A PHASE 3, MULTI-CENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY OF THE EFFICACY AND SAFETY OF APREMILAST IN SUBJECTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS OF THE SCALP

Mount Sinai St. Luke's
New York New York 10025

A randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the effect of secukinumab on aortic vascular inflammation and cardiometabolic biomarkers after 12 weeks of treatment, compared to placebo, and up to 52 weeks of treatment with secukinumab in adult subjects with moderate to severe chronic plaque-type psoriasis

Sadick Research Group
New York New York 10075

A Study of a Topical foam for the treatment of Psoriasis Vulgaris

The Rockefeller University Hospital
New York New York 10065

Comparative analysis of small and large plaque psoriasis

Sadick Research Group
New York New York 10075

Open Label Study to Evaluate the Efficacy of Etanercept Treatment in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed Therapy With Apremilast.

North Carolina

Duke Clinical Research Unit
Durham North Carolina 27710

A Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3041658 in Patients with Neutrophilic Skin Diseases

High Point Clinical Trials Center
High Point North Carolina 27265

Moderate to Severe Plaque Psoriasis Research Study

Pennsylvania

Rhode Island

Clinical Partners, LLC
Johnston Rhode Island 02919

Opportunity to participate: New Psoriasis Study Being Conducted

South Carolina

Coastal Carolina Research Center
Mount Pleasant South Carolina 29464

A Randomized, Double-Blind Study Comparing TOLMAR Calcipotriene and Betamethasone Suspension to Reference Listed Drug in the Treatment of Scalp Psoriasis

Tennessee

Texas

Research Across America
Dallas Texas

Pediatric Psoriasis Research Study

Research Across America, Plano
Plano Texas 75093

Plaque Psoriasis Research Study

Research Across America, Plano
Plano Texas

Plaque Psoriasis Research Study

Dermatology Clinical Research Center of San Antonio
San Antonio Texas 78229

A double-blind, randomized, parallel-group vehicle-controlled, multi-center study comparing a generic tazarotene cream, 0.05% to reference listed drug tazorac (tazarotene) cream, 0.05% and both active treatments to a vehicle control in the treatment of plaque psoriasis

Dermatology Clinical Research Center of San Antonio
San Antonio Texas 78229

A Phase 2, Randomized, Double-Blind, Multicenter, Parallel-Group, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dose Levels of XP23829 in Subjects with Moderate-to-Severe Chronic Plaque-Type Psoriasis

Dermatology Clinical Research Center of San Antonio
San Antonio Texas 78229

A single-arm study to assess the immunogenicity and safety of etanercept produced using a modified process in subjects with plaque psoriasis

Virginia

Charlottesville Medical Research
Charlottesville Virginia 22911

(V01-122A-301) A Phase 3, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP-122 in the Treatment of Plaque Psoriasis